GLP-1 weight management
Evaluated and prescribed by the licensed network where appropriate — you run the branded program and never prescribe.
Who it's for
Your own GLP-1 brand — without the pharmacy or liability
Demand for medical weight loss has never been higher — and the rules have never moved faster. Compounded supply, state prescribing rules and FDA enforcement shift constantly. Wellstaq matches every patient to an independent network licensed in their state that owns the evaluation, the prescribing, and the regulatory call on what can be offered and fulfilled, where permitted. Your durable revenue isn't the drug margin — it's the branded program around it: visits, monitoring, labs, supplements and adjacent hormone care, recurring under your name. When the rules change, that's the network's burden to absorb, not yours.
$0 to start$0 until you're liveno cardcancel anytime
WellStaq is a white-label telehealth platform that lets weight-loss and GLP-1 clinics connect bloodwork, licensed doctor consultations, eligible 503A pharmacy services, and optional supplements under their own brand. Independent clinicians control care; compounded drugs are not FDA-approved.
A recognizable model. Your own brand.
Build the Ro & Hims of weight loss — and own it
Think Function Health-style lab memberships and Hims-style access to care, brought together under your own brand. Start with bloodwork, connect members with a licensed doctor, then support appropriate next steps. These are business-model references, not affiliations; services and results differ.
The model members recognize
- Online telehealth visits at scale
- Provider-guided follow-up when appropriate
- Branded supplements and monthly memberships
Familiar access to care, with transparent clinical roles.
Your version
Bloodwork first. Your brand throughout.
- White-label telehealth and eligible 503A pharmacy pathways
- + blood labs and genetic reports
- + your brand and connected member experience
- + optional supplements and your own coaching
Launch in weeks, for a flat fee — no raise required.
Demand isn't the problem. The risk is.
Interest in medical weight loss has never been higher, and the programs are sticky — patients stay for months of visits, labs and refills. What stops clinics from scaling is everything around the prescription: shifting compounding rules, a different GLP-1 prescribing standard in every state, and the FDA and state attorneys general escalating enforcement against do-it-yourself telehealth and "research-grade" sourcing. Wellstaq removes that load — the platform runs your branded program and an independent 50-state network owns the clinical evaluation, the prescribing and the regulatory call on what can be offered and fulfilled, where permitted, so you can grow on demand instead of building a pharmacy.
flat $997/mo your cost does not rise as the program scales
What you can offer under your brand
Baseline and follow-up labs
Metabolic, A1c and lipid panels via Quest and LabCorp at wholesale; you set retail. The monitoring that keeps members enrolled and the program credible.
Branded supplement line
Protein, fiber and micronutrient support that protects results between refills — a recurring add-on on your own label, priced by you.
Telehealth check-ins
Provider visits for titration and monitoring, delivered by the network inside your branded app — the recurring touchpoints that drive retention.
Adjacent hormone programs
Many weight patients also screen for hormone issues; the network can evaluate TRT and HRT where appropriate, expanding lifetime value under the same brand.
You're not a prescriber — and you don't need to be
The fears that stop most weight-loss operators are the exact ones Wellstaq is built to remove. You don't prescribe: an independent, board-certified provider licensed in the patient's own state evaluates the GLP-1 category and owns every prescribing decision. You don't source: the independent network owns the regulatory call on what can be prescribed and fulfilled, where permitted, and availability remains subject to applicable law. This does not remove your own marketing, privacy, billing, or other legal obligations. You stay the brand, the program and the margin.
How it works for you
-
01
Patients enroll under your brand
Branded intake captures eligibility and health history before any clinical step — your name on the entire experience.
-
02
The network evaluates and prescribes
An independent provider licensed in the patient's state evaluates the GLP-1 category, owns prescribing where appropriate, and makes the regulatory call on what can be fulfilled, where permitted — never you.
-
03
You run the program and keep the margin
Earn from lawful products and nonclinical services. Medical and pharmacy fees are separate, not automatic brand-owner margin. Wellstaq charges a flat $997/mo and takes 0% of your sales.
Three paths — and why partners pick Wellstaq
You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.
Refer out to Ro & Hims
- You lose the patient to their brand
- $0 recurring revenue to you
- The member experience carries their brand
- Services and availability vary by provider
Build it yourself
- Build and maintain your own technology
- Arrange clinical, privacy, and legal support
- You vet compounders and track 50-state rules
- You build labs, pharmacy, app and supplements
Build it on Wellstaq
- Patients stay under your brand
- Recurring revenue you keep — flat $997/mo, live in weeks
- An independent 50-state network owns clinical + prescribing
- Labs, genetics, telehealth, 503A Rx and supplements — not just weight loss
- Earn from lawful products and nonclinical services; clinical billing stays separate
How the economics work
One platform fee. Build value beyond the test.
Standard $997/mo. First 100 Early Adopters: $297/mo with a lifetime price lock. Save $700/month — $8,400 every year on platform access. Lead with bloodwork, connect members with licensed telehealth and eligible 503A pharmacy services, and offer optional supplements, your own qualified coaching, and memberships. WellStaq takes 0% of your sales. Lab, clinical, pharmacy, product, and operating costs are separate; clinical fees and any management arrangements must follow applicable rules. No prescription commissions or earnings are promised.
Common questions about weight loss and glp-1
Can I offer a white-label GLP-1 program without being a prescriber?
Yes. In the Wellstaq model you never prescribe. An independent, board-certified provider licensed in the patient's state evaluates the GLP-1 category and owns the prescribing decision; you run the branded weight-management program — visits, monitoring, labs and supplements — around it.
Is compounded GLP-1 still available in 2026?
It is restricted and still changing. As the FDA-declared shortages of semaglutide and tirzepatide resolved, large-scale compounding of those GLP-1s has been wound down; 503A patient-specific compounding remains available only with a documented clinical need, where permitted. The independent network makes that regulatory call patient by patient — it is not yours to track.
How do I add GLP-1 weight loss to my practice or clinic?
You launch a branded program on the Wellstaq platform: patients intake under your name, an independent licensed network evaluates and prescribes where appropriate, and labs and supplements pass through at wholesale so you set retail and keep the margin. There is no pharmacy to build and no prescribing for you to do.
Programs that fit
Frequently asked questions
Can I offer GLP-1 weight loss if I'm not a prescriber?
Yes — you never prescribe. An independent, board-certified provider licensed in the patient's state evaluates the GLP-1 category and owns every prescribing decision. You run the brand and the program.
Who owns the clinical and regulatory call on what can be offered?
The independent network does. Its providers — licensed in each patient's state — decide what can be evaluated, prescribed and fulfilled, where permitted, and adapt as FDA and state rules change. You don't carry that regulatory exposure, and your durable revenue is the branded program around the care — visits, monitoring, labs, supplements and adjacent hormone care — not the drug itself.
How does prescribing work across multiple states?
Each patient is matched to a provider licensed in their own state, and eligibility depends on the service and state. Your business still needs state-specific review of billing, marketing, privacy, and operating arrangements.
What do I earn, and what does Wellstaq take?
You set retail on your program, labs and supplements and keep the margin over your wholesale cost. Wellstaq charges a flat $997/month and takes 0% of your sales. Every figure here is illustrative, not a guarantee of earnings.
What happens when compounding or shortage rules change?
The independent network owns the clinical and regulatory response and adapts the available pathways where permitted. Your brand and your member relationships stay intact while the compliance burden stays with the network.
Do I carry malpractice or handle patient records?
Independent licensed providers control clinical decisions. Your business remains responsible for its own marketing, privacy, billing, and scope-of-practice obligations; the platform does not eliminate liability.
Grow your GLP-1 program under your own brand
Save $700/month — $8,400/year. The first 100 Early Adopters to sign up get $297/mo locked in for life, instead of standard $997/mo. Join the free waitlist for your invitation when enrollment opens.
$0 to start$0 until you're liveno cardcancel anytime
WellStaq provides white-label telehealth technology and brand infrastructure, not medical care. Independent licensed providers make clinical and prescribing decisions. Eligible 503A pharmacy services require a valid patient-specific prescription and compliance with applicable requirements; availability varies. Compounded drugs are not FDA-approved. Provider and pharmacy identities remain disclosed. Health data is used only for permitted purposes with required safeguards and authorizations. Billing, marketing, privacy, and management arrangements need state-specific legal review. No health or earnings outcome is guaranteed.